References
Pankey GA (2005) Tigecycline. J Antimicrob Chemother 56:470–480
Wyeth. http://www.wyeth.com/content/getfile.asp?id=491, accessed 01 May 2009
Egi M, Morimatsu H, Wiedermann C, Tani M, Kanazawa T, Suzuki S, Matsusaki T, Shimizu K, Toda Y, Iwasaki T, Morita K (2009) Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels. Thromb Haemost 101:696–705
FDA. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/21-821_Tygacil_Medr.pdf
Zimmerman JJ, Raible DG, Harper DM, Matschke K, Speth JL (2008) Evaluation of a potential tigecycline–warfarin drug interaction. Pharmacotherapy 28:895–905
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pieringer, H., Schmekal, B., Biesenbach, G. et al. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline. Ann Hematol 89, 1063–1064 (2010). https://doi.org/10.1007/s00277-010-0911-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-010-0911-7